Patents by Inventor Anne Françoise Mayer

Anne Françoise Mayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8338144
    Abstract: The present invention discloses an isolated polynucleotide molecule derived from a polynucleotide encoding a polypeptide having L-sorbosone dehydrogenase activity comprising a partial nucleotide sequence of at least 20 consecutive nucleotides of SEQ ID NO:1. The present invention further relates to a process for the production of L-ascorbic acid in high yield, in particular a process using resting cells of a microorganism able to convert given carbon sources into vitamin C. The thus obtained vitamin C may be further processed by purification and/or separation steps.
    Type: Grant
    Filed: February 8, 2010
    Date of Patent: December 25, 2012
    Assignee: DSM IP Assets B.V.
    Inventors: Alan Berry, Connie Lee, Anne Françoise Mayer, Masako Shinjoh
  • Publication number: 20100203598
    Abstract: The present invention discloses an isolated polynucleotide molecule derived from a polynucleotide encoding a polypeptide having L-sorbosone dehydrogenase activity comprising a partial nucleotide sequence of at least 20 consecutive nucleotides of SEQ ID NO:1. The present invention further relates to a process for the production of L-ascorbic acid in high yield, in particular a process using resting cells of a microorganism able to convert given carbon sources into vitamin C. The thus obtained vitamin C may be further processed by purification and/or separation steps.
    Type: Application
    Filed: February 8, 2010
    Publication date: August 12, 2010
    Inventors: ALAN BERRY, CONNIE LEE, ANNE FRANCOISE MAYER, MASAKO SHINJOH
  • Patent number: 7700723
    Abstract: The present invention discloses an isolated polynucleotide molecule derived from a polynucleotide encoding a polypeptide having L-sorbosone dehydrogenase activity comprising a partial nucleotide sequence of at least 20 consecutive nucleotides of SEQ ID NO:1. The present invention further relates to a process for the production of L-ascorbic acid in high yield, in particular a process using resting cells of a microorganism able to convert given carbon sources into vitamin C. The thus obtained vitamin C may be further processed by purification and/or separation steps.
    Type: Grant
    Filed: August 16, 2004
    Date of Patent: April 20, 2010
    Assignee: DSM IP Assets B.V.
    Inventors: Alan Berry, Connie Lee, Anne Françoise Mayer, Masako Shinjoh
  • Patent number: 7232679
    Abstract: Isolated polynucleotides encoding polypeptides having the activity of enzymes in the mevalonate pathway are provided. These sequences are useful for recombinantly producing isoprenoid compounds, such as carotenoids, in particular zeaxanthin. Expression vectors, cultured cells, and methods of making isoprenoid compounds are also provided.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: June 19, 2007
    Assignee: DSM IP Assets B.V.
    Inventors: Alan Berry, Werner Bretzel, Markus Hümbelin, Rual Lopez-Ulibarri, Anne Françoise Mayer, Alexei A. Yeliseev
  • Patent number: 6989257
    Abstract: Isolated polynucleotides encoding polypeptides having the activity of enzymes in the mevalonate pathway are provided. These sequences are useful for recombinantly producing isoprenoid compounds, such as carotenoids, in particular zeaxanthin. Expression vectors, cultured cells, and methods of making isoprenoid compounds are also provided.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: January 24, 2006
    Assignee: DSM IP Assets B.V.
    Inventors: Alan Berry, Werner Bretzel, Markus Hümbelin, Rual Lopez-Ulibarri, Anne Françoise Mayer, Alexei A. Yeliseev
  • Publication number: 20030148416
    Abstract: Isolated polynucleotides encoding polypeptides having the activity of enzymes in the mevalonate pathway are provided. These sequences are useful for recombinantly producing isoprenoid compounds, such as carotenoids, in particular zeaxanthin. Expression vectors, cultured cells, and methods of making isoprenoid compounds are also provided.
    Type: Application
    Filed: June 5, 2002
    Publication date: August 7, 2003
    Applicant: ROCHE VITAMINS INC.
    Inventors: Alan Berry, Werner Bretzel, Markus Humbelin, Rual Lopez-Ulibarri, Anne Francoise Mayer, Alexei A. Yeliseev
  • Patent number: 6204012
    Abstract: A method for producing a protein by culturing a cell capable of expressing the protein and which contains a methylotrophic yeast promoter for an enzyme of the methanol metabolic pathway controlling expression of the protein, in a fermentative batch process comprising a batch phase and a feeding phase, under conditions such that dissolved oxygen is continually present in the culture medium throughout the process, and about 1% to about 100% of the carbon source during the feeding phase is a sugar or sugar polymer, which sugar or sugar polymer is provided in such an amount that the sugar or sugar polymer is continually depleted by the cell and therefore is substantially undetectable in the culture medium; and isolating the protein on completion of the feeding phase.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: March 20, 2001
    Assignee: Roche Vitamins Inc.
    Inventors: Karsten Hellmuth, Rual Lopez-Ulibarri, Anne Françoise Mayer, Heinrich Winfried Schlieker, Adolphus van Loon